Update: 09.07.2024
Last week: 26 week 2024 (24.06.2024 - 30.06.2024)
Last full month: June 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 823 | -3.4% | 12.2% | -0.1 | 13 976 510 | -3.2% | 9.5% | 0 | -2.8% |
| MoM | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| YTD | 186 655 | 19.0% | 11.2% | 2.4 | 411 049 498 | 43.3% | 9.4% | 2 | -6.8% |
| MAT | 370 596 | 27.3% | 10.3% | 1.9 | 781 015 618 | 46.9% | 8.7% | 1.5 | 4.1% |
| BRAINMAX | |||||||||
| WoW | 981 | -15.2% | 100.0% | 0 | 3 700 508 | -13.3% | 100.0% | 0 | -15.2% |
| MoM | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| YTD | 26 890 | 39.7% | 100.0% | 0 | 97 789 393 | 51.3% | 100.0% | 0 | 39.7% |
| MAT | 54 291 | 84.6% | 100.0% | 0 | 194 164 121 | 99.5% | 100.0% | 0 | 84.6% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 607 | -3.6% | 45.9% | 1.1 | 52 127 545 | -2.3% | 37.6% | 0.6 | -5.8% |
| MoM | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| YTD | 448 922 | -2.9% | 44.7% | 1.1 | 1 417 402 988 | 0.7% | 36.5% | -2.8 | -5.3% |
| MAT | 855 878 | 8.1% | 45.5% | 1.2 | 2 702 139 733 | 15.1% | 38.1% | -1.2 | 5.2% |
| MIGRENIUM | |||||||||
| WoW | 10 859 | 5.9% | 0.5% | 0 | 3 616 714 | 6.3% | 0.7% | 0 | -0.8% |
| MoM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| YTD | 311 599 | -2.0% | 0.5% | -0.1 | 94 732 542 | 64.8% | 0.7% | 0.2 | 12.1% |
| MAT | 635 105 | 1.2% | 0.5% | -0.1 | 159 896 958 | 40.3% | 0.6% | 0 | 16.1% |
| MODELAX-N | |||||||||
| WoW | 30 251 | -3.4% | 26.4% | -0.1 | 13 630 249 | -1.9% | 17.7% | 0.1 | -3.0% |
| MoM | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| YTD | 795 688 | 43.3% | 23.7% | 5 | 337 390 089 | 93.6% | 15.2% | 4.7 | 12.9% |
| MAT | 1 408 364 | 74.6% | 21.2% | 6.5 | 545 942 356 | 110.7% | 12.8% | 4.4 | 21.1% |
| REDUXIN | |||||||||
| WoW | 11 516 | -6.6% | 31.8% | -0.2 | 62 001 581 | -3.1% | 44.7% | 0.3 | -5.8% |
| MoM | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| YTD | 330 827 | -8.7% | 32.9% | -1.2 | 1 785 883 886 | 17.0% | 46.0% | 3.4 | -5.3% |
| MAT | 606 439 | -1.5% | 32.3% | -2.2 | 3 132 531 221 | 22.2% | 44.2% | 1.3 | 5.2% |
| REDUXIN FORTE | |||||||||
| WoW | 3 183 | -11.3% | 8.8% | -0.5 | 13 991 844 | -8.4% | 10.1% | -0.5 | -5.8% |
| MoM | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| YTD | 87 521 | 2.5% | 8.7% | 0.7 | 380 781 533 | 18.1% | 9.8% | 0.8 | -5.3% |
| MAT | 168 189 | 19.2% | 9.0% | 1.1 | 711 854 041 | 32.5% | 10.0% | 1 | 5.2% |
| SALVISAR | |||||||||
| WoW | 8 288 | -6.5% | 1.2% | 0 | 3 677 251 | -4.2% | 1.2% | 0 | -3.5% |
| MoM | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
| YTD | 271 604 | 2.2% | 1.4% | 0 | 108 800 496 | 26.6% | 1.2% | 0.1 | 0.9% |
| MAT | 504 158 | -12.5% | 1.2% | -0.3 | 186 616 668 | -4.0% | 1.1% | -0.3 | 6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 186 655 | 19.0% | 11.2% | 2.4 | 411 049 498 | 43.3% | 9.4% | 2 | -6.8% |
| BRAINMAX | 26 890 | 39.7% | 100.0% | 0 | 97 789 393 | 51.3% | 100.0% | 0 | 39.7% |
| GOLDLINE PLUS | 448 922 | -2.9% | 44.7% | 1.1 | 1 417 402 988 | 0.7% | 36.5% | -2.8 | -5.3% |
| MIGRENIUM | 311 599 | -2.0% | 0.5% | -0.1 | 94 732 542 | 64.8% | 0.7% | 0.2 | 12.1% |
| MODELAX-N | 795 688 | 43.3% | 23.7% | 5 | 337 390 089 | 93.6% | 15.2% | 4.7 | 12.9% |
| REDUXIN CAPS | 330 827 | -8.7% | 32.9% | -1.2 | 1 785 883 886 | 17.0% | 46.0% | 3.4 | -5.3% |
| REDUXIN FORTE | 87 521 | 2.5% | 8.7% | 0.7 | 380 781 533 | 18.1% | 9.8% | 0.8 | -5.3% |
| SALVISAR | 271 604 | 2.2% | 1.4% | 0 | 108 800 496 | 26.6% | 1.2% | 0.1 | 0.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 370 596 | 27.3% | 10.3% | 1.9 | 781 015 618 | 46.9% | 8.7% | 1.5 | 4.1% |
| BRAINMAX | 54 291 | 84.6% | 100.0% | 0 | 194 164 121 | 99.5% | 100.0% | 0 | 84.6% |
| GOLDLINE PLUS | 855 878 | 8.1% | 45.5% | 1.2 | 2 702 139 733 | 15.1% | 38.1% | -1.2 | 5.2% |
| MIGRENIUM | 635 105 | 1.2% | 0.5% | -0.1 | 159 896 958 | 40.3% | 0.6% | 0 | 16.1% |
| MODELAX-N | 1 408 364 | 74.6% | 21.2% | 6.5 | 545 942 356 | 110.7% | 12.8% | 4.4 | 21.1% |
| REDUXIN CAPS | 606 439 | -1.5% | 32.3% | -2.2 | 3 132 531 221 | 22.2% | 44.2% | 1.3 | 5.2% |
| REDUXIN FORTE | 168 189 | 19.2% | 9.0% | 1.1 | 711 854 041 | 32.5% | 10.0% | 1 | 5.2% |
| SALVISAR | 504 158 | -12.5% | 1.2% | -0.3 | 186 616 668 | -4.0% | 1.1% | -0.3 | 6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 823 | -3.4% | 12.2% | -0.1 | 13 976 510 | -3.2% | 9.5% | 0 | -2.8% |
| BRAINMAX | 981 | -15.2% | 100.0% | 0 | 3 700 508 | -13.3% | 100.0% | 0 | -15.2% |
| GOLDLINE PLUS | 16 607 | -3.6% | 45.9% | 1.1 | 52 127 545 | -2.3% | 37.6% | 0.6 | -5.8% |
| MIGRENIUM | 10 859 | 5.9% | 0.5% | 0 | 3 616 714 | 6.3% | 0.7% | 0 | -0.8% |
| MODELAX-N | 30 251 | -3.4% | 26.4% | -0.1 | 13 630 249 | -1.9% | 17.7% | 0.1 | -3.0% |
| REDUXIN CAPS | 11 516 | -6.6% | 31.8% | -0.2 | 62 001 581 | -3.1% | 44.7% | 0.3 | -5.8% |
| REDUXIN FORTE | 3 183 | -11.3% | 8.8% | -0.5 | 13 991 844 | -8.4% | 10.1% | -0.5 | -5.8% |
| SALVISAR | 8 288 | -6.5% | 1.2% | 0 | 3 677 251 | -4.2% | 1.2% | 0 | -3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| BRAINMAX | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| GOLDLINE PLUS | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| MIGRENIUM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| MODELAX-N | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| REDUXIN CAPS | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| REDUXIN FORTE | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| SALVISAR | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs